alexa Blood Pressure in Renal Disease: Objectives, Surrogate Markers and Treatment
ISSN: 2168-9857

Medical & Surgical Urology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Conference Proceeding

Blood Pressure in Renal Disease: Objectives, Surrogate Markers and Treatment

Robles NR*

Cardiovascular Risk Chair, Universidad de Salamanca, Salamanca, Spain

*Corresponding Author:
Nicolás Roberto Robles
Unidad de HTA, Hospital Infanta Cristina
Carretera de Portugal s/n, 06080, Badajoz, Spain
E-mail: [email protected]

Received date: November 30, 2012; Accepted date: December 28, 2012; Published date: December 30, 2012

Citation: Robles NR (2013) Blood Pressure in Renal Disease: Objectives, Surrogate Markers and Treatment. Med Surg Urol S11:002. doi:10.4172/2168-9857.S11-002

Copyright: © 2013 Robles NR. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



Despite decades of trials, we still are uncertain as to what level we should lower BP to achieve maximalcardiovascular protection in hypertensive patients. Even more, nowadays the target for reducing blood pressure inrenal disease is under discussion; there is scanty evidence from randomized clinical trials to support a straight bloodpressure control for proteinuric patients.

On the other hand the value of microalbuminuria as surrogate marker of renal disease progression is controversialin hypertensive non diabetic patients. Furthermore, frequently the effects of treatment on glomerular filtration rate themore used and useful test for chronic kidney disease- are opposite in several clinical trials.

The Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension(ACCOMPLISH) trial showed that initial antihypertensive therapy with benazepril plus amlodipine was superior to benazepril plus hydrochlorothiazide in reducing progression of chronic kidney disease as well as cardiovascular morbidityand mortality in renal patients. The renal results of the ACCOMPLISH trial strongly support the recommendation ofusing calcium channel blockers as second antihypertensive agent added to renin-angiotensin axis blocking drugs. Thevalidity of this data and its relationship with the cumulated evidence on the effects of calcium antagonists (especially new calcium channel blockers which reduce proteinuria) on renal disease progression will be discussed.

Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version